UPDATE: Other Monograph meetings have now been scheduled for March, June and November 2024. The next possible slot for RF radiation is in early 2025.
On November 23, Elisabete Weiderpass, the Director of the International Agency for Research on Cancer (IARC), revealed that a new assessment of the evidence linking radiofrequency (RF) radiation to cancer would likely take place in early 2024. A formal decision could come within a few months.
Calls for a new IARC evaluation have been mounting for some years following the release of two large animal studies showing elevated tumor counts after lifelong exposure to RF radiation. Many believe that the animal experiments leave the Agency little choice but to increase the cancer risk classification at least one notch to “probable” from the current “possible,” or perhaps to its highest classification, a known human carcinogen.
But, as Weiderpass made clear on making the announcement at a conference in Paris, the RF–cancer risk might instead be downgraded and the “possible” classification removed.
The stakes are high.
